there. Do you have a preference when you're working with a brand, would you rather,
which, you know, in your perfect world is a brand bootstrapped to $5 million and you guys come
in there and at that point it's the right time to scale things up. Do you have a preference for
“the brands that you work with and they're financing profile that they've architected to that point?”
I think this is why there is the beauty of the Northwest platform. I know this sounds self-serving to say, but because we had this, it allows us to meet them wherever they are. And so if you're bootstrapped and you're profitable and we've seen very successful businesses that have that profile, that is a good fit for a private equity team. And then if there is just some, you know, differentiated advantage, we can figure out about this business, then then I'd rather actually
give them some capital upfront to just get out to market and be able to have the resources to hire the best team to invest in the clinical studies and do something truly differentiated to create
kind of the splash in the momentum around it. So the answer is no. Yeah, you can, you could pursue
either path. Very cool. Next one is awareness of buyer appetite, you know, what, one of the things that a founder will eventually learn is like, whether you create a bootstrapped profile of business or when that goes public one day, it takes the same amount of time, you know, like because you're obsessing about it all day long. And so in the most valuable asset and commodity in
“our life is our time. And so if you really want to maximize strategic value, which is, you know,”
create an interesting business that generates healthy revenue and margins that somebody will buy, which that's where you get the extra kicker, right? Like in you, you scale a business to 100 million in someone pays by times revenue for that, that 100 million revenue business can sell for 500 million. But if you build a business that no one cares about to buy, then you're kind of stuck at this 100 million, but still could be a great lifestyle business, right? It's cashflow and
etc. So they're both successful paths. I think it's just, if you're going to be talking to an institutional investor, they are eventually looking for an exit and they're eventually looking to maximize the entire value of the business. That this is where you just want to play in lanes where you know there is appetite to make acquisitions and they're done at premium multiples. And which is why you are seeing that in personal care and in supplements, which is why you see a lot
of investors flocking to that area. You know, other areas like a peril is that it is just harder, even though you can have breakout brands there, is that it can trade at one time's revenue multiple and sometimes even lower than that too. And so, you know, 100 million revenue business, you can either choose the lane that trades at a one to two times revenue multiple or you can choose the lane that trades at five times revenue multiple and that's going to be the difference of
which lane you play in terms of the buyer appetite. Beautiful. I imagine some verticals are just like with a peril for instance, it's going to come with a lot more, it's going to come with a different set of headaches than something like supplements in a way, right? You've got sizes, you've got breakage, you've got the fact that you probably have to get to retail in order to achieve either your own retail or wholesale in order to get to that nine figure plus mark,
whereas I feel like a good supplement funnel, you know, can really be run through digital ads a
“lot easier than something like a parallel. Is that true? Yeah, I think that's true. I think there's”
more loyalty that can be created. Of course, we're talking generalization, so this is not in all companies that are big of a parallel companies that can be built, but there is more loyalty that you can have in supplements. There's something in the beauty category that's called the lipstick effect, and that means during times of recession, the consumer can still buy that lipstick and feel beautiful. I think that that's the case in supplements, too, right? Is like during times of recession,
if you actually look at the data, supplements actually continue to grow and be one of the more durable categories through down periods in the market. And that's because you're able to continue to buy that supplement and investing your health, feel like you're investing in your health, and maybe that's going to save you the trip to the doctor. And so there's just more resilience
in the category in general. And the last one is something I think founders are always interested
in hearing when you take money, how much should you pay yourself, how much operational discipline should you have? Yeah, so I, you know, when we talk about pain, pain oneself is that I do think that you want to create enough that they can feel comfortable, and that they're not just worried about day-to-day life, so they can sit and be very strategic in just the business. But you do want to be disciplined. And this is goes beyond just what is pain themselves. It's just how do you actually
focus and drive a sustainable growth? You know, a lot of our conversation comes back to how do you